Delivery Order SPE2DB20D2014-SPE2DB24FA17M
Award Date 10/23/23
Potential Completion Date 10/24/23
Potential Value $4.2K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide 4,558,986,354 units of Naloxone HCL 4 mg nasal spray. The contract has a ceiling value of $11,337.85 and an ultimate completion date of November 4, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Cencora, Inc., valued at up to $999,999,999.00 and running through...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $41,796.44 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the procurement of 4,563,589,049 units of Naloxone HCl 4 mg Nasal Spray. The Delivery Order has a period of performance through February 8, 2024 and uses a Firm Fixed Price pricing type. The contract was awarded on February 7, 2024 with no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of 4,562,139,657 units of Naloxone HCl 4 mg Nasal Spray, a critical medication used for the treatment of opioid overdose. The contract has a ceiling value of $1,199.86 and a completion date of September 13, 2023. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency (DLA) awarded a $3,011.02 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,560,832,406 units of Naloxone HCL 4 mg nasal spray. This delivery order contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
- This federal contract award, valued at $4,707.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,560,941,949 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to reverse opioid overdoses. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., to provide 4,560,749 units of Naloxone 2 mg/2 ml Syringe 2 ml. The $7,190.06 Firm Fixed Price contract has an ultimate completion date of April 28, 2023. This Delivery Order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, which runs through November 2026. The contract is not...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,562,252,687 units of Naloxone HCL 4 mg nasal spray. The contract has a Firm Fixed Price (FFP) pricing type, a ceiling value of $46,516.61, and an ultimate completion date of September 21, 2023. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora,...
- This federal contract award, valued at $3,010.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,043,264 units of NALOXONE HCL 4 MG NASAL SPRAY 2S, a critical medication used to treat opioid overdose. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999 and running through...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,320.69 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,664,956 units of 4 mg naloxone hydrochloride nasal spray. This order is part of a larger indefinite delivery contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and...
- This federal contract award is for the delivery of 4,559,669,970 units of Naloxone HCL 4 mg Nasal Spray 2s to the Defense Logistics Agency (DLA). The $21,883.38 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between Cencora, Inc. and the DLA Troop Support Medical, which provides a comprehensive range of...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FA17MDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,562,568,315 units of Naloxone HCL 4 mg Nasal Spray. The contract, valued at $4,240.56, has an ultimate completion date of October 24, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC allows the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. No set-aside requirements were specified for this contract award.
Generated 5/12/25, 10:16 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 10/23/23 |